Literature DB >> 15051810

Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity.

Rita Crinelli1, Marzia Bianchi, Lucia Gentilini, Linda Palma, Mads D Sørensen, Torsten Bryld, Ravindra B Babu, Khalil Arar, Jesper Wengel, Mauro Magnani.   

Abstract

Double-stranded oligonucleotides (ODNs) containing the consensus binding sequence of a transcription factor provide a rationally designed tool to manipulate gene expression at the transcriptional level by the decoy approach. However, modifications introduced into oligonucleotides to increase stability quite often do not guarantee that transcription factor affinity and/or specificity of recognition are retained. We have previously evaluated the use of locked nucleic acids (LNA) in the design of decoy molecules for the transcription factor kappaB. Oligo nucleotides containing LNA substitutions displayed high resistance to exo- and endonucleolytic degradation, with LNA-DNA mix-mers being more stable than LNA-DNA-LNA gap-mers. However, insertion of internal LNA bases resulted in a loss of affinity for the transcription factor. This latter effect apparently depended on positioning of the internal LNA substitutions. Indeed, here we demonstrate that intra- and inter-strand positioning of internal LNAs has to be carefully considered to maintain affinity and achieve high stability, respectively. Unfortunately, our data also indicate that LNA positioning is not the only parameter affecting transcription factor binding, the interference in part being dependent on the intrinsic conformational properties of this nucleotide analog. To circumvent this problem, the successful use of an alpha-L-ribo- configured LNA is demonstrated, indicating LNA-DNA-alpha-L-LNA molecules as promising new decoy agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051810      PMCID: PMC390358          DOI: 10.1093/nar/gkh503

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

Review 1.  Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA.

Authors:  D A Braasch; D R Corey
Journal:  Chem Biol       Date:  2001-01

Review 2.  Transcription factors as potential targets for therapeutic drugs.

Authors:  D S Latchman
Journal:  Curr Pharm Biotechnol       Date:  2000-07       Impact factor: 2.837

Review 3.  Molecular therapy via transcriptional regulation with double-stranded oligodeoxynucleotides as decoys.

Authors:  Hiroshige Nakamura; Ryuichi Morishita; Yasufumi Kaneda
Journal:  In Vivo       Date:  2002 Jan-Feb       Impact factor: 2.155

4.  LNA (locked nucleic acid) and the diastereoisomeric alpha-L-LNA: conformational tuning and high-affinity recognition of DNA/RNA targets.

Authors:  J Wengel; M Petersen; K E Nielsen; G A Jensen; A E Håkansson; R Kumar; M D Sørensen; V K Rajwanshi; T Bryld; J P Jacobsen
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2001 Apr-Jul       Impact factor: 1.381

Review 5.  Therapeutic modulation of transcription factor activity.

Authors:  J G Emery; E H Ohlstein; M Jaye
Journal:  Trends Pharmacol Sci       Date:  2001-05       Impact factor: 14.819

6.  Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides.

Authors:  M Magnani; L Rossi; A Fraternale; M Bianchi; A Antonelli; R Crinelli; L Chiarantini
Journal:  Gene Ther       Date:  2002-06       Impact factor: 5.250

7.  Design and characterization of decoy oligonucleotides containing locked nucleic acids.

Authors:  Rita Crinelli; Marzia Bianchi; Lucia Gentilini; Mauro Magnani
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

8.  Structure of NF-kappaB p50/p65 heterodimer bound to the PRDII DNA element from the interferon-beta promoter.

Authors:  Carlos R Escalante; Leyi Shen; Dimitris Thanos; Aneel K Aggarwal
Journal:  Structure       Date:  2002-03       Impact factor: 5.006

9.  Molecular interactions with nuclear factor kappaB (NF-kappaB) transcription factors of a PNA-DNA chimera mimicking NF-kappaB binding sites.

Authors:  A Romanelli; C Pedone; M Saviano; N Bianchi; M Borgatti; C Mischiati; R Gambari
Journal:  Eur J Biochem       Date:  2001-12

10.  alpha-L-ribo-configured locked nucleic acid (alpha-L-LNA): synthesis and properties.

Authors:  Mads D Sørensen; Lisbet Kvaernø; Torsten Bryld; Anders E Håkansson; Birgit Verbeure; Gilles Gaubert; Piet Herdewijn; Jesper Wengel
Journal:  J Am Chem Soc       Date:  2002-03-13       Impact factor: 15.419

View more
  9 in total

1.  First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

Authors:  Malabika Sen; Sufi M Thomas; Seungwon Kim; Joanne I Yeh; Robert L Ferris; Jonas T Johnson; Umamaheswar Duvvuri; Jessica Lee; Nivedita Sahu; Sonali Joyce; Maria L Freilino; Haibin Shi; Changyou Li; Danith Ly; Srinivas Rapireddy; Jonathan P Etter; Pui-Kai Li; Lin Wang; Simion Chiosea; Raja R Seethala; William E Gooding; Xiaomin Chen; Naftali Kaminski; Kusum Pandit; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancer Discov       Date:  2012-06-20       Impact factor: 39.397

2.  DNA minicircles as novel STAT3 decoy oligodeoxynucleotides endowed with anticancer activity in triple-negative breast cancer.

Authors:  Geoffrey Casas; Federico Perche; Patrick Midoux; Chantal Pichon; Jean-Marc Malinge
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-22       Impact factor: 10.183

3.  Functionalized 2'-amino-alpha-L-LNA: directed positioning of intercalators for DNA targeting.

Authors:  T Santhosh Kumar; Andreas S Madsen; Michael E Østergaard; Sujay P Sau; Jesper Wengel; Patrick J Hrdlicka
Journal:  J Org Chem       Date:  2009-02-06       Impact factor: 4.354

Review 4.  Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis.

Authors:  Maryam Mahjoubin-Tehran; Yong Teng; Amin Jalili; Seyed Hamid Aghaee-Bakhtiari; Alexander M Markin; Amirhossein Sahebkar
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

5.  Palytoxin and an Ostreopsis toxin extract increase the levels of mRNAs encoding inflammation-related proteins in human macrophages via p38 MAPK and NF-κB.

Authors:  Rita Crinelli; Elisa Carloni; Elisa Giacomini; Antonella Penna; Sabrina Dominici; Cecilia Battocchi; Patrizia Ciminiello; Carmela Dell'Aversano; Ernesto Fattorusso; Martino Forino; Luciana Tartaglione; Mauro Magnani
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

Review 6.  Nucleic acid-based approaches to STAT inhibition.

Authors:  Malabika Sen; Jennifer R Grandis
Journal:  JAKSTAT       Date:  2012-10-01

7.  C5-alkynyl-functionalized α-L-LNA: synthesis, thermal denaturation experiments and enzymatic stability.

Authors:  Pawan Kumar; Bharat Baral; Brooke A Anderson; Dale C Guenther; Michael E Østergaard; Pawan K Sharma; Patrick J Hrdlicka
Journal:  J Org Chem       Date:  2014-05-13       Impact factor: 4.354

8.  Lipid-modified G4-decoy oligonucleotide anchored to nanoparticles: delivery and bioactivity in pancreatic cancer cells.

Authors:  S Cogoi; U Jakobsen; E B Pedersen; S Vogel; L E Xodo
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

9.  Inorganic Kernel-Reconstituted Lipoprotein Biomimetic Nanovehicles Enable Efficient Targeting "Trojan Horse" Delivery of STAT3-Decoy Oligonucleotide for Overcoming TRAIL Resistance.

Authors:  Kai Shi; Jianxiu Xue; Yan Fang; Hongshu Bi; Shan Gao; Dongjuan Yang; Anqi Lu; Yuai Li; Yao Chen; Liyuan Ke
Journal:  Theranostics       Date:  2017-10-12       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.